Oxaliplatin-Induced Peripheral Neuropathy’s Effects on Colorectal Cancer Survivors Cindy Tofthagen, PhD, ARNP, AOCNP Assistant Professor University of.

Slides:



Advertisements
Similar presentations
Mental Health: assessment and rehabilitation Dr Doreen Miller FRCP FFOM Managing Partner Miller Health Management.
Advertisements

Is Caregiver Depression Associated with Children’s ADHD Symptoms and Overall Functioning? Randi Scott SUMR Final Presentation August 07, 2008.
Development and initial validation of the ‘Bristol Impact of Hypermobility’ (BIoH) questionnaire ST Palmer a, F Cramp a, R Lewis b, G Gould c, E Clark.
Consequences of Treatment for Rectal Cancer Gillian Knowles, Rachel Haigh, Catriona McLean, Hamish Phillips, Malcolm Dunlop, Farhat Din.
The primary care excellence model Increasing Colorectal Cancer Screening Uptake with a Patient Navigator Dr. Brian Mitchell, Co-Investigator Northern Ontario.
Cross-Cultural Use of Measurements: Development of the Chinese SF-36 Health Survey Xinhua S. Ren, Ph.D. Boston University School of Public Health, Boston,
 Lowell Smith Sr. Director, Business & Communication Research Administration Moffitt Cancer Center  Jeanine Stiles Chief Administrative Officer Associate.
Statistics for Health Care
Janice H. Goodman, PhD..  “Perinatal depression is associated with potential negative consequences for the mother and infant, and therefore efforts to.
COGNITIVE APPROACHES TO SUICIDE Center for Disease Control and Prevention February 6, 2004 Aaron T. Beck, M.D. Gregory K. Brown, Ph.D. University of Pennsylvania.
As noted by Gary H. Lyman (JCO, 2012) “CER is an important framework for systematically identifying and summarizing the totality of evidence on the effectiveness,
Conclusions Male breast cancer survivors experience substantial symptoms Hormonal symptoms are prevalent in male breast cancer survivors; in men without.
® Introduction Mental Health Predictors of Pain and Function in Patients with Chronic Low Back Pain Olivia D. Lara, K. Ashok Kumar MD FRCS Sandra Burge,
® Introduction Low Back Pain Remedies and Procedures: Helpful or Harmful? Lauren Lyons, Terrell Benold, MD, Sandra Burge, PhD The University of Texas Health.
TERMINATION OF LONG-TERM MENTAL HEALTH TREATMENT WITH FOSTER YOUTH Kimberlin Borca, Foster Care Research Group University of San Francisco April 29, 2012.
Rivka Herman 1 *,RN. M.Sc Michal Libergal 1 *, PhD; David Rott 2, MD Michal Libergal 1 *, PhD; David Rott 2, MD 1 Henrietta Szold Hadassah-Hebrew University.
Knowledge, Cancer Fatalism and Spirituality as Predictors of Breast Cancer Screening Practices for African American and Caucasian Women Staci T. Anderson,
Prevalence and Correlates of Depressive Symptoms in Pregnancy African American Women Nancy Jallo, PhD, FNP-BC, WHNP-BC Virginia Commonwealth University.
 Abstract For women newly diagnosed with breast cancer, psychosocial distress may interfere with their ability to cope with cancer treatment. Nurses should.
Comorbidity in SLE Compared with Rheumatoid Arthritis and Non-inflammatory Disorders Frederick Wolfe 1, Kaleb Michaud 1,2, Tracy Li 3, Robert S. Katz 4.
Symptom Management and Quality of Life at the End of Life Susan C. McMillan, PhD, ARNP, FAAN Professor, College of Nursing Center for Hospice, Palliative.
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
A comparison of barriers to physical activity faced by older and younger adults with mobility impairments Vijay Vasudevan,
Nursing Care Makes A Difference The Application of Omaha Documentation System on Clients with Mental Illness.
Yesterday, today, and tomorrow
Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium/Magnesium to Prevent Oxaliplatin- Induced Sensory Neurotoxicity, N08CB.
Chair Timothy L. Vollmer, MD Professor of Neurology
Testing People Scientifically.  Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each.
Telephone-based coping skills training for patients awaiting lung transplantation The INSPIRE Investigators Duke University Medical Center, Durham, NC.
RESILIENCE RESOURCES CONTRIBUTE TO BETTER HEALTH OUTCOMES AMONG RHEUMATOIC ARTHRITIS PATIENTS Kate E. Murray, B.A., Brendt P. Parrish, B.S., Mary C. Davis,
Statistics for Health Care Biostatistics. Phases of a Full Clinical Trial Phase I – the trial takes place after the development of a therapy and is designed.
Interferences between depression and life quality on patients suffering of type 2 diabetes First Author : Madalina Crisan Coauthors: Madalina Salagean.
Participants were recruited from 6 drug free, psychosocial treatment (PT) and 5 methadone maintenance (MM) programs (N = 628) participating in a NIDA Clinical.
Parent Child Interaction Therapy in Head Start Families Jane G. Querido, M.S. And Sheila M. Eyberg, Ph.D. Department of Clinical and Health Psychology,
Consent for Research Study A study using 18 F-Fluoride for prostate cancer patients currently enrolled in Dr. Febbo’s “Genomic Guided Therapy” study A.
Do Instrumental Activities of Daily Living Predict Dementia at 1- and 2- Year Follow-Up? Findings from the Development of Screening Guidelines and Diagnostic.
Lecture 9: Analysis of intervention studies Randomized trial - categorical outcome Measures of risk: –incidence rate of an adverse event (death, etc) It.
Consent for Research Study A study for patients newly diagnosed with advanced glioblastoma (brain cancer): Learning whether a PET scan with F-fluoromisonidazole.
Adverse Outcomes After Hospitalization and Delirium in Persons with Alzheimer Disease Charles Wang, PharmD Candidate.
RNSG 1163 Summer Qe8cR4Jl10.
1 Lecture 6: Descriptive follow-up studies Natural history of disease and prognosis Survival analysis: Kaplan-Meier survival curves Cox proportional hazards.
® Changes in Opioid Use Over One Year in Patients with Chronic Low Back Pain Alejandra Garza, Gerald Kizerian, PhD, Sandra Burge, PhD The University of.
1 Impact of Implementing Designed Nursing Intervention Protocol on Clinical Outcome of Patient with Peptic Ulcer By Amal Mohamed Ahmad Assistant Professor,
Smoking and Mental Health Problems in Treatment-Seeking University Students Eric Heiligenstein, M.D. University of Wisconsin-Madison Health Services Stevens.
F UNCTIONAL L IMITATIONS IN C ANCER S URVIVORS A MONG E LDERLY M EDICARE B ENEFICIARIES Prachi P. Chavan, MD, MPH Epidemiology PhD Student Xinhua Yu MD.
INTRODUCTION Emotional distress and sense of burden are experienced by many caregivers of persons with traumatic brain injury (TBI). 1-8 Predicting which.
Targeting Taxane-Induced NeuropathyWith Exercise Constance Visovsky PhD, RN, APRN-NP Associate Dean of Student Affairs & Director Community Engagement.
Determinants of Subjective Memory Complaints in Community-dwelling Adults with Traumatic Brain Injury Esther Bay, PhD; Bruno Giordani, PhD; Claire Kalpakjian,
Quality of Life (QOL) & Patient Reported Outcomes (PRO) Lori Minasian, MD Chief, Community Oncology and Prevention Trials Research Group, DCP, NCI, NIH,
1 Information Systems Use Among Ohio Registered Nurses: Testing Validity and Reliability of Nursing Informatics Measurements Amany A. Abdrbo, RN, MSN,
Research into Practice Audiology Chemotherapy Ototoxicity Project.
INTRODUCTION Research suggests that use of online social networking sites (SNS) can have positive and negative effects on users. The way that individuals.
Health-Related Quality of Life and Loneliness for Ischemic and Hemorrhagic Stroke Survivors Living in Appalachia Laurie Theeke PhD, Patricia Horstman MSN,
Predictors of Functioning in Women with Fibromyalgia Syndrome (FMS) Alexa Stuifbergen, PhD, RN, FAAN Professor Dolores V.Sands Chair in Nursing Research.
The Influence of Comorbidities on Use of Symptom Management Strategies in a Cancer Patient Intervention Gerontological Society of America November 19,
Health Related Quality of Life after serious occupational injuries and long term disability Presenter: Ibishi Nazmie MD,PhD University Clinical Center.
Presenter:Ibishi Nazmie MD, PhD University Clinical Center of Kosovo Clinic Of Psychiatry Mesic Srebrenka, Nebi Musliu.
Generalized Logit Model
Methodological challenges of studying CIPN during chemotherapy
Quality of Medical Care Received by Individuals with Mental Illnesses
Pediatric Psychology: An Overview
School of Physical Therapy METHODS – DATA ANALYSIS
Impact of Functioning on the Career Development of Young Adult CNS Survivors David R. Strauser, Ph.D.
Pelvic floor muscle assessment in patients who have undergone general rehabilitation following surgery for colorectal cancer: a pilot study Kuan-Yin.
University of South Alabama Neurobehavioural Associates
The Impact Of Pediatric Critical Illness, Injury, Complex Medical Conditions And Disabilities On Families Office of Rare Diseases and the National Institute.
ALIVE! About Living Enhancements After Breast Cancer
Physical and Psychological Sequelae of Breast Cancer in Men
Physical Activity and Endometrial Cancer Survival
Patient-reported Outcome Measures
Presentation transcript:

Oxaliplatin-Induced Peripheral Neuropathy’s Effects on Colorectal Cancer Survivors Cindy Tofthagen, PhD, ARNP, AOCNP Assistant Professor University of South Florida Postdoctoral Fellow University of Massachusetts Boston and Dana Farber Cancer Institute

Background over 1,000,000 survivors of colorectal 1 in 19 people will develop colorectal cancer during their lifetime (NCI, 2012) the risk of mortality from colorectal cancer has declined over the last twenty years because of early detection and new treatment alternatives like oxaliplatin (NCI, 2010). Oxaliplatin was approved by the Food and Drug Administration (FDA) for treatment of metastatic colorectal cancer in 2002 and approved for first-line adjuvant treatment of stage III colorectal cancer in 2004 (NCI, 2010).

Background Oxaliplatin is highly toxic to the peripheral nervous system Cause chronic neurotoxicity in up to 50% of patients that can persist for years following completion of chemotherapy. Neurotoxicities may not develop until after completion of chemotherapy Primarily effects sensory neurons

Purpose To examine severity of neuropathic symptoms and evaluate relationships between neuropathic symptoms, health- related quality of life, depressive symptoms and sleep in colorectal survivors who were treated with oxaliplatin.

Sample & Setting Men and women with a history of stage III – IV colorectal cancer treated with oxaliplatin at the Moffitt Cancer Center between 1 and 8 years previously. Eligibility criteria: at least 18 years of age; treated with oxaliplatin for stage III – IV colorectal cancer have no history of cancer other than colorectal cancer no other potentially neuropathy-inducing condition (e.g., diabetes) no documented or psychiatric or neurologic disorders that would interfere with study participation be able to speak and read standard English provide written informed consent.

Procedures The Institutional Review Board approved the study Patients were identified through the Moffitt Cancer Center Cancer Registry Potentially eligible survivors were contacted by telephone to confirm eligibility and obtain verbal informed consent Survivors who provided verbal consent were then mailed a study packet and postage paid return envelope Approximately 1 week later, those survivors who had not yet returned the packet were contacted by telephone and prompted to complete and return the material A total of 128 survivors agreed to participate. 111 (94%) survivors completed and returned the study packet

Instruments Chemotherapy Induced Peripheral Neuropathy Assessment Tool (CIPNAT) The Center for Epidemiological Studies-Depression Scale (CES-D) Insomnia Severity Index (ISI) Medical Outcomes Study Short Form- 36 (SF-36) Demographic Data Form

Power & Data Analysis A priori power analysis indicated that 108 subjects were needed, at 90% power and 2-sided type I error rate of 0.01, to detect a 10% or more change in R-square (percentage of variation explained) attributed independently to level of neuropathic symptoms. Correlation coefficients, simple regression and multiple linear regression analysis were used to examine relationships between neuropathy and depressive symptoms, sleep quality, and health-related quality of life (HRQOL).

Results-Demographics 51% male 88% Caucasian 71% stage 3 colon cancer 37% still employed (not retired or disabled) Mean of 3 years since oxaliplatin based chemotherapy

Prevalence of Symptoms

Severity of Symptoms

Symptom Distress

Frequency of Symptoms

Correlations Between CIPN, Depressive Symptoms and Sleep VariableSymptom ExperienceSymptom Interference Depressive Symptoms (CES-D).38 (p=.001).59 (p<.001) Sleep Disturbance (ISS).35 (p=.004).52 (p<.001)

Correlations Between CIPN and QOL Symptom experience r p Symptom interference r p Physical functioning <.0001 Role emotional <.0001 Role physical <.0001 Bodily pain <.0001 Vitality <.0001 General health Mental health <.0001 Social functioning <.0001

Cluster Analysis VariableInstrument Cluster 1 (n=21) Mean (SD) Cluster 2 (n=56) Mean (SD) Cluster 3 (n=17) Neuro SymptomsCIPNAT (37.73) (49.93) (58.43) Depressive symptomsCES-D 2.48 (3.14) (7.07) (14.47) InsomniaSSI 1.43 (1.54) 8.75 (5.32) (6.79) AgeDemographic data (7.52) (11.66) (9.32) General Health (norm based) SF (3.11) (4.90) (4.71) Physical Functioning (norm based) SF (13.54) (11.58) (12.98) Emotional Role Function (norm based) SF (0.00) (6.08) (15.80)

Discussion Colorectal cancer survivors continue to experience oxaliplatin-induced peripheral neuropathy that adversely affects emotional and physical well-being and quality of life for years following treatment There is a subset of colorectal cancer survivors who experience severe neuropathy that affects their ability to carry out usual activities, and is associated with increased depressive symptoms, sleep disturbance and reduced quality of life.

Limitations Relatively small sample, cross-sectional design, convenience sampling Lack of racial and ethnic diversity While our findings suggest that neuropathy contributes to depressive symptoms, insomnia, and reduced quality of life, it is possible that persons with a high degree of depressive symptoms and/or insomnia are more likely to report more severe neuropathic symptoms and neuropathic interference with activities.

Directions for Future Research and Practice Longitudinal studies using larger sample sizes and more diverse racial and ethnic groups Identification of possible modifiable and non-modifiable risk factors for severe neuropathy that may influence treatment decisions Interventions to relieve symptoms and improving physical performance Survivorship programs should include systematic assessment for neuropathy, provide rehabilitation when needed, and develop support programs for colorectal cancer survivors which emphasize the chronic nature of neuropathy, help maximize performance status,and assist patients in adjusting to and coping with physical and role limitations.

Acknowledgements Co-Investigators Kristine A. Donovan, PhD, MBA Moffitt Cancer Center & Research Institute Mary Ann Morgan, PhD, ARNP Moffitt Cancer Center & Research Institute David Shibata, MD FACS Moffitt Cancer Center and Research Institute

Acknowledgements Data analysis - Yating Yeh, PhD Dana-Farber Cancer Institute Funding – USF Nursing Faculty in Pilot Research Projects and the University of Massachusetts Boston - Dana Farber /Harvard Cancer Center U54 Cancer Research Partnership